Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Activation of PDGFRA by genomic aberrations contributes to tumor progression in several tumor types. Here, the authors perform functional characterization of 16 novel PDGFRA mutations identified from different tumor types and demonstrate that a neomorphic PDGFRA extracellular domain driver mutation...
Guardado en:
Autores principales: | Carman K. M. Ip, Patrick K. S. Ng, Kang Jin Jeong, S. H. Shao, Zhenlin Ju, P. G. Leonard, Xu Hua, Christopher P. Vellano, Richard Woessner, Nidhi Sahni, Kenneth L. Scott, Gordon B. Mills |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5afbb5f4318a4d348864297344880429 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
por: Debyani Chakravarty, et al.
Publicado: (2017) -
Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
por: Mariarita Sciumè, et al.
Publicado: (2021) -
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
por: Maximilian Y. Deng, et al.
Publicado: (2021) -
A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis
por: Yanzhe Gao, et al.
Publicado: (2016) -
The pathologic effect of a novel neomorphic Fgf9(Y162C) allele is restricted to decreased vision and retarded lens growth.
por: Oliver Puk, et al.
Publicado: (2011)